Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

James Miller

Concepts (326)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
44
2020
2159
2.870
Why?
Smoking
20
2019
1382
1.320
Why?
Bronchi
13
2018
223
1.260
Why?
Carcinoma in Situ
5
2019
44
1.130
Why?
Carcinoma, Squamous Cell
10
2018
577
0.800
Why?
Carcinogens
4
2012
102
0.780
Why?
Chemoprevention
3
2019
87
0.740
Why?
Vascular Endothelial Growth Factor Receptor-2
2
2012
86
0.740
Why?
Lung
16
2020
3521
0.660
Why?
Carcinoma, Small Cell
7
2008
158
0.510
Why?
Bronchoscopy
9
2019
196
0.510
Why?
Bronchopulmonary Dysplasia
2
2019
333
0.500
Why?
Urethane
3
2012
41
0.490
Why?
Sputum
8
2019
286
0.480
Why?
Pulmonary Alveoli
4
2012
373
0.470
Why?
Iloprost
2
2012
46
0.470
Why?
Hyperplasia
7
2011
163
0.470
Why?
Precancerous Conditions
7
2020
155
0.450
Why?
Neprilysin
3
1998
47
0.430
Why?
Biomarkers, Tumor
7
2015
1032
0.420
Why?
Antineoplastic Agents
4
2013
1875
0.410
Why?
Piperidines
2
2012
159
0.410
Why?
Quinazolines
2
2012
240
0.400
Why?
Biopsy
11
2019
1024
0.400
Why?
DNA Copy Number Variations
1
2011
153
0.360
Why?
Genetic Markers
1
2011
320
0.350
Why?
Bombesin
5
1998
12
0.350
Why?
Carcinoma, Non-Small-Cell Lung
7
2013
959
0.340
Why?
Amidohydrolases
3
1998
28
0.340
Why?
Mass Screening
3
2008
979
0.330
Why?
Neurosecretory Systems
4
2004
32
0.330
Why?
Vasodilator Agents
1
2011
302
0.320
Why?
Isotretinoin
1
2009
22
0.320
Why?
Ki-67 Antigen
3
2015
102
0.320
Why?
Tocopherols
1
2009
22
0.320
Why?
ErbB Receptors
1
2012
554
0.320
Why?
Membrane Proteins
2
2008
1016
0.310
Why?
Pulmonary Disease, Chronic Obstructive
4
2018
907
0.300
Why?
Neovascularization, Pathologic
6
2015
280
0.290
Why?
Respiratory Mucosa
2
2008
252
0.280
Why?
Adenocarcinoma
6
2012
787
0.270
Why?
Hypoxia
1
2012
956
0.260
Why?
Middle Aged
28
2019
26620
0.240
Why?
Aged
25
2019
18973
0.230
Why?
Chromosomes, Human, Pair 3
4
2000
49
0.230
Why?
Chromosome Aberrations
4
2013
134
0.220
Why?
Carcinoma, Bronchogenic
2
2002
17
0.220
Why?
Humans
53
2020
114077
0.210
Why?
Female
33
2019
59347
0.210
Why?
Tomography, Spiral Computed
1
2002
23
0.210
Why?
Sensitivity and Specificity
10
2010
1690
0.190
Why?
Double-Blind Method
2
2019
1656
0.190
Why?
Smokers
2
2019
129
0.190
Why?
Lung Diseases
5
2015
690
0.190
Why?
Tomography, X-Ray Computed
2
2020
2273
0.190
Why?
Male
30
2019
55418
0.190
Why?
Small Cell Lung Carcinoma
2
2012
77
0.180
Why?
Placebos
2
2019
197
0.180
Why?
Tumor Cells, Cultured
6
1998
845
0.170
Why?
Neuropeptides
4
1998
63
0.160
Why?
Radiographic Image Interpretation, Computer-Assisted
1
2020
98
0.160
Why?
Remission Induction
1
2019
233
0.160
Why?
Peptides
3
1996
847
0.160
Why?
In Situ Hybridization, Fluorescence
6
2010
308
0.150
Why?
Blotting, Western
4
2012
1143
0.150
Why?
Antibodies, Monoclonal
3
2010
1257
0.140
Why?
Genes, p53
1
1997
61
0.140
Why?
Lung Diseases, Obstructive
1
1997
40
0.140
Why?
Proteomics
2
2015
815
0.140
Why?
Immunohistochemistry
8
2015
1624
0.140
Why?
Point Mutation
1
1997
216
0.140
Why?
Mice
10
2012
14847
0.130
Why?
Animals
13
2013
31570
0.130
Why?
Bradykinin
1
1996
41
0.130
Why?
Radiation Injuries, Experimental
1
1996
24
0.130
Why?
Endopeptidases
1
1996
70
0.130
Why?
Chromosomal Instability
2
2013
18
0.130
Why?
Smoking Cessation
1
2019
374
0.120
Why?
Risk Factors
5
2019
8612
0.120
Why?
Multiple Pulmonary Nodules
1
2015
22
0.120
Why?
Hyperoxia
1
1996
99
0.120
Why?
Aged, 80 and over
8
2015
6307
0.120
Why?
Gene Expression
3
1998
1417
0.120
Why?
Mice, Transgenic
5
2009
1947
0.110
Why?
Antigens
1
1996
317
0.110
Why?
Mutation
4
2000
3338
0.110
Why?
Algorithms
3
2020
1469
0.110
Why?
Methylcholanthrene
2
2012
18
0.110
Why?
Butylated Hydroxytoluene
2
2012
31
0.110
Why?
Stem Cells
1
2018
541
0.110
Why?
Microarray Analysis
1
2013
118
0.110
Why?
Epithelium
4
2018
295
0.110
Why?
Biological Products
1
1996
166
0.110
Why?
Intramolecular Oxidoreductases
2
2004
57
0.110
Why?
Epithelial Cells
3
2007
946
0.110
Why?
Risk
5
2012
810
0.100
Why?
Carcinoma, Large Cell
1
2012
14
0.100
Why?
Cytochrome P-450 Enzyme System
2
2004
108
0.100
Why?
Case-Control Studies
8
2012
3007
0.100
Why?
Bronchoalveolar Lavage Fluid
3
2002
580
0.100
Why?
Receptors, Bombesin
1
2012
2
0.100
Why?
Volatile Organic Compounds
1
2012
45
0.100
Why?
Cell Division
4
2000
754
0.100
Why?
Immunoenzyme Techniques
1
2012
192
0.100
Why?
Veterans
1
2002
1248
0.100
Why?
Sleep Apnea Syndromes
1
2012
74
0.090
Why?
Dose-Response Relationship, Drug
2
2010
1837
0.090
Why?
Proto-Oncogene Proteins c-myc
1
2012
116
0.090
Why?
Chromosomes, Human, Pair 15
1
2011
53
0.090
Why?
Eosinophilic Granuloma
1
1990
3
0.090
Why?
Epithelial-Mesenchymal Transition
1
2012
167
0.090
Why?
Adult
16
2018
30394
0.090
Why?
Basic Helix-Loop-Helix Transcription Factors
1
2012
225
0.090
Why?
Disease Progression
5
2018
2371
0.090
Why?
Antioxidants
2
2012
529
0.090
Why?
Genome-Wide Association Study
2
2013
1176
0.090
Why?
Calcium
1
1996
1089
0.090
Why?
Proteins
1
1996
906
0.090
Why?
Predictive Value of Tests
4
2009
1791
0.090
Why?
Cell Line
5
2013
2629
0.090
Why?
Cell Proliferation
2
2018
2173
0.080
Why?
Plants, Toxic
1
1989
22
0.080
Why?
Somatomedins
1
2009
28
0.080
Why?
Intracellular Signaling Peptides and Proteins
2
2011
388
0.080
Why?
Chromosome Deletion
1
1989
94
0.080
Why?
Bronchial Neoplasms
1
2009
13
0.080
Why?
Neoplasms, Glandular and Epithelial
1
2009
34
0.080
Why?
Neoplasm Invasiveness
4
2015
438
0.080
Why?
Respiratory System
1
1989
137
0.080
Why?
GPI-Linked Proteins
1
2008
54
0.080
Why?
Airway Obstruction
3
2009
160
0.070
Why?
Inflammation
1
2018
2465
0.070
Why?
Fluorescence
3
2009
148
0.070
Why?
Polymorphism, Genetic
1
2011
610
0.070
Why?
Alkaline Phosphatase
1
2008
142
0.070
Why?
Fibroblasts
3
1998
836
0.070
Why?
Spectral Karyotyping
1
2007
5
0.070
Why?
Molecular Targeted Therapy
1
2010
347
0.070
Why?
Isoenzymes
1
2008
283
0.070
Why?
Early Detection of Cancer
1
2010
305
0.070
Why?
Proto-Oncogene Proteins p21(ras)
1
2008
228
0.070
Why?
Cell Transformation, Neoplastic
1
2009
307
0.070
Why?
Pulmonary Surfactants
2
1999
99
0.070
Why?
Molecular Sequence Data
5
1998
2783
0.070
Why?
Exons
2
1998
301
0.070
Why?
Follow-Up Studies
2
2015
4392
0.070
Why?
MicroRNAs
1
2012
600
0.070
Why?
Polymorphism, Single Nucleotide
1
2013
1880
0.070
Why?
Biomarkers
3
2010
3397
0.070
Why?
ROC Curve
3
2015
441
0.060
Why?
Enzyme-Linked Immunosorbent Assay
3
2005
787
0.060
Why?
Adaptor Proteins, Signal Transducing
1
2008
367
0.060
Why?
Recombinant Proteins
3
1998
1228
0.060
Why?
RNA, Messenger
3
1998
2550
0.060
Why?
Polymerase Chain Reaction
3
1998
990
0.060
Why?
Protein Kinase Inhibitors
1
2010
784
0.060
Why?
Cytokines
1
2012
1824
0.060
Why?
Growth Hormone-Releasing Hormone
1
2004
26
0.060
Why?
Acromegaly
1
2004
12
0.060
Why?
Rats
4
2004
4913
0.060
Why?
Neoplasm Recurrence, Local
1
2009
850
0.060
Why?
Adrenocorticotropic Hormone
1
2004
128
0.050
Why?
Cross-Sectional Studies
2
2018
4404
0.050
Why?
Smoke
1
2004
123
0.050
Why?
Base Sequence
3
1998
2114
0.050
Why?
Solitary Pulmonary Nodule
1
2002
19
0.050
Why?
Metaplasia
2
2018
54
0.050
Why?
Sex Factors
1
2007
1707
0.050
Why?
Vascular Endothelial Growth Factor A
1
2005
496
0.050
Why?
Pulmonary Fibrosis
2
1998
321
0.050
Why?
Radiation Dosage
1
2002
133
0.050
Why?
Hospitals, Veterans
1
2002
244
0.050
Why?
Reproducibility of Results
1
2008
2764
0.050
Why?
Cohort Studies
4
2015
4884
0.040
Why?
Gene Expression Regulation
1
1989
2322
0.040
Why?
Feasibility Studies
1
2002
735
0.040
Why?
Amino Acid Sequence
3
1994
1981
0.040
Why?
Signal Transduction
3
1998
4501
0.040
Why?
Gastrin-Releasing Peptide
2
1996
6
0.040
Why?
Light
1
2001
336
0.040
Why?
Autocrine Communication
1
1998
42
0.040
Why?
gamma Catenin
1
2018
17
0.040
Why?
Gene Expression Profiling
1
2005
1519
0.040
Why?
Desmoglein 3
1
2018
17
0.040
Why?
Loss of Heterozygosity
2
2013
40
0.040
Why?
Up-Regulation
2
2005
802
0.040
Why?
DNA Primers
2
1998
508
0.040
Why?
Paracrine Communication
1
1998
55
0.040
Why?
Bronchial Diseases
1
2018
35
0.040
Why?
United States
2
2011
12144
0.040
Why?
Neoplasm Transplantation
1
1998
227
0.040
Why?
Cell Cycle Checkpoints
1
2018
84
0.040
Why?
Time
1
2018
70
0.040
Why?
Vascular Cell Adhesion Molecule-1
1
1998
35
0.040
Why?
Telangiectasia, Hereditary Hemorrhagic
1
1998
10
0.040
Why?
Genes, Tumor Suppressor
1
1998
77
0.040
Why?
Polymorphism, Single-Stranded Conformational
1
1997
25
0.040
Why?
Alveolitis, Extrinsic Allergic
1
1998
83
0.040
Why?
Neoplasm Staging
2
2012
1162
0.040
Why?
Likelihood Functions
1
1998
126
0.040
Why?
Polymorphism, Restriction Fragment Length
1
1997
65
0.040
Why?
DNA, Complementary
1
1998
255
0.040
Why?
Treatment Outcome
1
2011
9050
0.040
Why?
Gene Expression Regulation, Enzymologic
1
1998
270
0.040
Why?
Codon
1
1997
85
0.040
Why?
Introns
1
1998
227
0.040
Why?
Membrane Glycoproteins
1
1999
429
0.030
Why?
Mice, Nude
1
1998
628
0.030
Why?
Incidence
3
2010
2314
0.030
Why?
Machine Learning
1
2020
315
0.030
Why?
Immunoassay
2
1998
95
0.030
Why?
Enzyme Activation
1
1998
771
0.030
Why?
Image Processing, Computer-Assisted
1
2020
684
0.030
Why?
RNA, Neoplasm
1
1996
80
0.030
Why?
Mesothelioma
1
1996
31
0.030
Why?
Glycopeptides
1
1996
43
0.030
Why?
Antigens, CD
2
1998
440
0.030
Why?
Databases, Factual
1
2020
1127
0.030
Why?
Sequence Analysis, DNA
1
1998
722
0.030
Why?
Proto-Oncogene Proteins
1
2018
607
0.030
Why?
Cell Cycle Proteins
1
2018
549
0.030
Why?
Prospective Studies
3
2012
6198
0.030
Why?
Myelin Sheath
1
1996
138
0.030
Why?
Receptors, Peptide
1
1994
15
0.030
Why?
Liver Neoplasms
1
1998
504
0.030
Why?
Rh-Hr Blood-Group System
1
1994
11
0.030
Why?
Neoplasm Metastasis
1
1996
521
0.030
Why?
Erythrocyte Membrane
1
1994
50
0.030
Why?
Blotting, Southern
1
1993
68
0.030
Why?
Blotting, Northern
1
1993
193
0.030
Why?
Endoscopy
1
2015
245
0.030
Why?
Cells, Cultured
2
2007
3862
0.030
Why?
Colorado
1
2002
4092
0.030
Why?
Gene Expression Regulation, Neoplastic
1
2018
1144
0.030
Why?
DNA, Neoplasm
1
1993
155
0.030
Why?
Solid Phase Microextraction
1
2012
6
0.030
Why?
Enzyme Inhibitors
1
1996
743
0.030
Why?
Dinoprostone
2
2004
183
0.030
Why?
Fluorescent Antibody Technique
1
1993
396
0.030
Why?
Breath Tests
1
2012
82
0.030
Why?
Gas Chromatography-Mass Spectrometry
1
2012
121
0.030
Why?
Cloning, Molecular
1
1993
522
0.020
Why?
Iceland
1
2011
6
0.020
Why?
Respiratory Tract Diseases
1
1992
139
0.020
Why?
Tumor Suppressor p53-Binding Protein 1
1
2011
12
0.020
Why?
Spain
1
2011
32
0.020
Why?
Netherlands
1
2011
64
0.020
Why?
Rats, Sprague-Dawley
1
1996
2182
0.020
Why?
Cattle
1
1993
918
0.020
Why?
Administration, Oral
1
2012
725
0.020
Why?
Severity of Illness Index
1
2018
2540
0.020
Why?
Prognosis
2
2012
3315
0.020
Why?
Meta-Analysis as Topic
1
2011
156
0.020
Why?
Carrier Proteins
1
1994
694
0.020
Why?
Flow Cytometry
1
1993
1075
0.020
Why?
Receptor, IGF Type 1
1
2009
58
0.020
Why?
Cystic Fibrosis
1
1998
955
0.020
Why?
Area Under Curve
1
2010
273
0.020
Why?
Erythrocytes
1
1994
568
0.020
Why?
International Agencies
1
2009
29
0.020
Why?
Pilot Projects
1
2012
1361
0.020
Why?
Chromatography, High Pressure Liquid
1
1989
465
0.020
Why?
Mass Spectrometry
1
2010
622
0.020
Why?
Genome, Human
1
2009
347
0.020
Why?
Models, Statistical
1
2010
595
0.020
Why?
Disease Models, Animal
1
1996
3499
0.020
Why?
Amino Acids
1
1989
445
0.020
Why?
Genotype
1
2011
1757
0.020
Why?
Receptors, Vascular Endothelial Growth Factor
1
2005
103
0.010
Why?
Genomics
1
2009
631
0.010
Why?
Epoprostenol
1
2004
133
0.010
Why?
Bronchiolitis
1
2004
81
0.010
Why?
Autoantibodies
1
2010
1350
0.010
Why?
Pituitary Neoplasms
1
2004
156
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2005
924
0.010
Why?
Fruit
1
2003
119
0.010
Why?
Genetic Predisposition to Disease
1
2011
2090
0.010
Why?
Vegetables
1
2003
133
0.010
Why?
Respiratory Function Tests
1
2004
522
0.010
Why?
Adenoma
1
2004
187
0.010
Why?
Oligonucleotide Array Sequence Analysis
1
2004
742
0.010
Why?
Weight Gain
1
2004
453
0.010
Why?
Regression Analysis
1
2003
945
0.010
Why?
Single-Blind Method
1
2001
259
0.010
Why?
Platelet Endothelial Cell Adhesion Molecule-1
1
2000
57
0.010
Why?
Carcinoma
1
2001
198
0.010
Why?
RNA
1
2005
806
0.010
Why?
Retrospective Studies
1
2015
12521
0.010
Why?
Bronchoscopes
1
1998
2
0.010
Why?
Endoglin
1
1998
20
0.010
Why?
Random Allocation
1
1998
328
0.010
Why?
Reference Values
1
1998
739
0.010
Why?
Genetic Linkage
1
1998
294
0.010
Why?
Longitudinal Studies
1
2003
2388
0.010
Why?
Comorbidity
1
2001
1447
0.010
Why?
Tumor Suppressor Protein p53
1
2000
445
0.010
Why?
Diet
1
2003
1080
0.010
Why?
Linear Models
1
1998
768
0.010
Why?
Receptors, Cell Surface
1
1998
350
0.010
Why?
Young Adult
1
2011
10458
0.010
Why?
Analysis of Variance
1
1998
1218
0.010
Why?
Alleles
1
1998
789
0.010
Why?
Infant, Premature
1
1998
478
0.010
Why?
Risk Assessment
1
2004
2958
0.010
Why?
CD47 Antigen
1
1994
21
0.010
Why?
Chromatography, Affinity
1
1994
80
0.010
Why?
Endothelium, Vascular
1
2000
830
0.010
Why?
Moths
1
1994
34
0.010
Why?
Genes
1
1994
223
0.010
Why?
Electrophoresis, Polyacrylamide Gel
1
1994
315
0.010
Why?
Cytoplasm
1
1994
255
0.010
Why?
Adolescent
1
2011
17811
0.010
Why?
Chromosome Mapping
1
1994
486
0.010
Why?
Carcinoid Tumor
1
1992
23
0.010
Why?
Lymphocytes
1
1994
327
0.010
Why?
Transfection
1
1994
863
0.010
Why?
Mice, Inbred BALB C
1
1994
1144
0.010
Why?
Dyspnea
1
1992
212
0.010
Why?
Binding Sites
1
1994
1166
0.010
Why?
Fibrosis
1
1992
452
0.010
Why?
Phenotype
1
1998
2784
0.010
Why?
Aging
1
1998
1612
0.000
Why?
Infant, Newborn
1
1998
5038
0.000
Why?
Infant
1
1998
7945
0.000
Why?
Child, Preschool
1
1998
9120
0.000
Why?
Child
1
1998
18408
0.000
Why?
Miller's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)